Login / Signup

4E-BP1-dependent translation in nociceptors controls mechanical hypersensitivity via TRIM32/type I interferon signaling.

Calvin WongDiana Tavares-FerreiraCarolina Thörn PérezBehrang SharifSonali UttamMehdi AmiriKevin C ListerMehdi HooshmandiVivienne NguyenPhilippe SéguélaNahum SonenbergTheodore John PriceChristos G GkogkasArkady Khoutorsky
Published in: Science advances (2023)
Activation of the mechanistic target of rapamycin complex 1 (mTORC1) contributes to the development of chronic pain. However, the specific mechanisms by which mTORC1 causes hypersensitivity remain elusive. The eukaryotic initiation factor 4E-binding protein 1 (4E-BP1) is a key mTORC1 downstream effector that represses translation initiation. Here, we show that nociceptor-specific deletion of 4E-BP1, mimicking activation of mTORC1-dependent translation, is sufficient to cause mechanical hypersensitivity. Using translating ribosome affinity purification in nociceptors lacking 4E-BP1, we identified a pronounced translational up-regulation of tripartite motif-containing protein 32 (TRIM32), an E3 ubiquitin ligase that promotes interferon signaling. Down-regulation of TRIM32 in nociceptors or blocking type I interferon signaling reversed the mechanical hypersensitivity in mice lacking 4E-BP1. Furthermore, nociceptor-specific ablation of TRIM32 alleviated mechanical hypersensitivity caused by tissue inflammation. These results show that mTORC1 in nociceptors promotes hypersensitivity via 4E-BP1-dependent up-regulation of TRIM32/interferon signaling and identify TRIM32 as a therapeutic target in inflammatory pain.
Keyphrases
  • chronic pain
  • drug induced
  • dendritic cells
  • binding protein
  • oxidative stress
  • pain management
  • immune response
  • mass spectrometry
  • spinal cord
  • insulin resistance
  • high fat diet induced
  • type iii
  • postoperative pain